[Skip to Content]
[Skip to Content Landing]
Views 135
Citations 0
Correction
December 19, 2019

Error in the Author Affiliation

JAMA Ophthalmol. 2020;138(2):223. doi:10.1001/jamaophthalmol.2019.5606

In the Original Investigation titled “Economic Value of Anti–Vascular Endothelial Growth Factor Treatment for Patients With Wet Age-Related Macular Degeneration in the United States,”1 published online November 11, 2019, Dr Goldman’s affiliations were incomplete. In addition to the Leonard D. Schaeffer Center for Health Policy and Economics, Dr Goldman is affiliated with the Sol Price School of Public Policy and the School of Pharmacy at the University of Southern California. This article was corrected online.

References
1.
Mulligan  K, Seabury  SA, Dugel  PU, Blim  JF, Goldman  DP, Humayun  MS.  Economic value of anti–vascular endothelial growth factor treatment for patients with wet age-related macular degeneration in the United States  [published online November 11, 2019].  JAMA Ophthalmol. doi:10.1001/jamaophthalmol.2019.4557PubMedGoogle Scholar
×